These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9405226)

  • 1. Haloenol lactone: a new synergist of chemotherapy in vitro.
    Zheng J; Wurz GT; Cadman TB; Degregorio MW; Jones AD; Hammock BD
    Biochem Biophys Res Commun; 1997 Dec; 241(1):13-7. PubMed ID: 9405226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme.
    Wang W; Liu G; Zheng J
    Eur J Pharmacol; 2007 Jul; 568(1-3):61-7. PubMed ID: 17509556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and structure-activity relationships of haloenol lactones: site-directed and isozyme-selective glutathione S-transferase inhibitors.
    Wu Z; Minhas GS; Wen D; Jiang H; Chen K; Zimniak P; Zheng J
    J Med Chem; 2004 Jun; 47(12):3282-94. PubMed ID: 15163208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic study of potentiation of chemotherapy by a haloenol lactone derivative in vitro.
    Wang W; Xia CQ; Liu N; Gan LS; Zheng J
    Cancer Chemother Pharmacol; 2008 Jun; 62(1):117-22. PubMed ID: 17899085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haloenol lactone is a new isozyme-selective and active site-directed inactivator of glutathione S-transferase.
    Zheng J; Mitchell AE; Jones AD; Hammock BD
    J Biol Chem; 1996 Aug; 271(34):20421-5. PubMed ID: 8702779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional consequences of haloenol lactone inactivation of murine and human glutathione S-transferase.
    Mitchell AE; Zheng J; Hammock BD; Lo Bello M; Jones AD
    Biochemistry; 1998 May; 37(19):6752-9. PubMed ID: 9578559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A newly synthesized bifunctional inhibitor, CKA1083, enhances adriamycin activity against human ovarian carcinoma cells.
    Maeda O; Kikkawa F; Tamakoshi K; Obata NH; Mizuno K; Suganuma N; Tomoda Y; Kuzuya K; Ishikawa T; Hidaka H
    Anticancer Res; 1997; 17(3C):1985-92. PubMed ID: 9216655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of multidrug resistance by small interfering double-stranded RNAs in ovarian cancer cells.
    Zhang T; Guan M; Jin HY; Lu Y
    Gynecol Oncol; 2005 May; 97(2):501-7. PubMed ID: 15863151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation of cisplatin sensitivity in cisplatin-resistant human bladder cancer cells by modulating glutathione concentrations and glutathione-related enzyme activities.
    Byun SS; Kim SW; Choi H; Lee C; Lee E
    BJU Int; 2005 May; 95(7):1086-90. PubMed ID: 15839938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of glutathione S-transferase M1 by new gabosine analogues is essential for overcoming cisplatin resistance in lung cancer cells.
    Wang CH; Wu HT; Cheng HM; Yen TJ; Lu IH; Chang HC; Jao SC; Shing TK; Li WS
    J Med Chem; 2011 Dec; 54(24):8574-81. PubMed ID: 22085405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of glutathione transferase-pi in untreated primary non-small-cell lung cancer.
    Arai T; Yasuda Y; Takaya T; Hayakawa K; Toshima S; Shibuya C; Kashiki Y; Yoshimi N; Shibayama M
    Cancer Detect Prev; 2000; 24(3):252-7. PubMed ID: 10975287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent isozyme-selective inhibition of human glutathione S-transferase A1-1 by a novel glutathione S-conjugate.
    Cacciatore I; Caccuri AM; Cocco A; De Maria F; Di Stefano A; Luisi G; Pinnen F; Ricci G; Sozio P; Turella P
    Amino Acids; 2005 Nov; 29(3):255-61. PubMed ID: 16082503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of multiple drug resistance in cholangiocarcinoma by the glutathione S-transferase-pi-specific inhibitor O1-hexadecyl-gamma-glutamyl-S-benzylcysteinyl-D-phenylglycine ethylester.
    Nakajima T; Takayama T; Miyanishi K; Nobuoka A; Hayashi T; Abe T; Kato J; Sakon K; Naniwa Y; Tanabe H; Niitsu Y
    J Pharmacol Exp Ther; 2003 Sep; 306(3):861-9. PubMed ID: 12805482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Glutathione S transferases-pi].
    Takahashi Y; Niitsu Y
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):945-51. PubMed ID: 8002632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors.
    Cullen KJ; Newkirk KA; Schumaker LM; Aldosari N; Rone JD; Haddad BR
    Cancer Res; 2003 Dec; 63(23):8097-102. PubMed ID: 14678959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione.
    Geroni C; Marchini S; Cozzi P; Galliera E; Ragg E; Colombo T; Battaglia R; Howard M; D'Incalci M; Broggini M
    Cancer Res; 2002 Apr; 62(8):2332-6. PubMed ID: 11956092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic studies of inactivation of glutathione S-transferase Pi isozyme by a haloenol lactone derivative.
    Zheng J; Liu G; Tozkoparan B; Wen D
    Med Chem; 2005 Mar; 1(2):191-8. PubMed ID: 16787314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione derivatives enhance adriamycin cytotoxicity in a human lung adenocarcinoma cell line.
    Nakanishi Y; Matsuki H; Takayama K; Yatsunami J; Kawasaki M; Abe M; Hara N
    Anticancer Res; 1997; 17(3C):2129-34. PubMed ID: 9216676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arsenic trioxide in the mechanism of drug resistance reversal in MCF-7/ADM cell line of human breast cancer.
    Wang X; Kong L; Zhao J; Yang P
    Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):339-43. PubMed ID: 12408759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro reversal of glutathione-S-transferase-mediated resistance in canine osteosarcoma (COS31) cells.
    Shoieb AM; Hahn KA; Van Laack RL; Barnhill MA
    In Vivo; 1998; 12(5):455-62. PubMed ID: 9827351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.